Integra LifeSciences Holdings
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +12.2% | +19.0% | +142.9% | +52.9% | +43.8% | +20.5% | +64.8% | +23.8% | +20.9% | +50.9% | +31.3% | +18.9% | +4.3% | +7.3% | +6.6% | +6.5% | +0.6% | +11.0% | -4.9% | +12.4% | +19.8% | +23.9% | +3.1% | -9.6% | +12.4% | +1.0% | -1.0% | +4.5% | +1.5% | |
| – | +10.6% | +17.3% | +257.4% | +23.0% | +34.3% | +27.1% | +54.2% | +23.7% | +20.9% | +59.5% | +27.5% | +17.8% | -3.1% | +9.5% | +11.5% | +5.1% | +6.3% | +5.6% | -7.4% | +6.9% | +24.8% | +31.2% | -1.2% | -7.8% | +14.8% | -1.7% | +11.8% | +10.9% | +8.4% | |
| – | +13.1% | +20.0% | +81.6% | +84.4% | +50.4% | +16.4% | +72.0% | +23.9% | +21.0% | +45.6% | +33.8% | +19.7% | +8.9% | +6.0% | +3.7% | +7.4% | -2.8% | +14.6% | -3.4% | +15.6% | +17.1% | +19.7% | +5.8% | -10.7% | +11.0% | +2.7% | -8.8% | -0.3% | -4.2% | |
| – | +1.6% | +31.3% | +3.6% | -13.5% | +6.2% | +3.9% | +54.3% | +10.2% | -15.3% | +115.2% | +19.1% | +97.3% | -26.8% | +8.7% | +6.9% | -0.9% | +2.1% | -0.9% | -1.4% | +14.3% | +9.1% | +23.0% | +2.0% | -2.8% | +20.3% | +8.8% | +3.0% | +10.7% | -14.2% | |
| – | +111.5% | -22.2% | +40.5% | +97.5% | -26.2% | +25.4% | +46.5% | +67.1% | -1.1% | +60.5% | +42.8% | +24.8% | +0.0% | +8.5% | +17.4% | +4.2% | +5.7% | +13.1% | -6.8% | +9.6% | +37.0% | +10.7% | -0.5% | -13.5% | +7.2% | -3.3% | +6.5% | +9.2% | -2.4% | |
| – | +59.2% | -10.5% | +29.8% | +70.9% | -23.7% | +5.1% | +66.2% | +56.3% | -1.2% | +65.3% | +39.7% | +32.0% | -4.1% | +7.5% | +16.7% | +3.9% | +3.7% | +11.1% | -6.5% | +10.7% | +34.2% | +11.6% | +8.8% | -18.6% | +6.8% | -2.1% | +5.7% | +10.4% | -9.0% | |
| – | – | – | – | – | – | +34.3% | +106.6% | -37.5% | +126.4% | +4.7% | +14.5% | -29.5% | +106.3% | +0.9% | -44.4% | +34.4% | -104.9% | – | +21.4% | +44.9% | -61.2% | +147.7% | -15.5% | +61.4% | +30.3% | +21.1% | -53.3% | -74.5% | +140.5% | |
| – | – | – | – | – | – | – | – | – | – | – | +29.5% | +118.8% | -22.8% | -21.0% | +50.6% | -19.5% | -11.3% | +11.4% | +7.1% | +9.7% | +35.7% | +84.7% | -16.6% | +32.7% | -29.6% | -1.6% | +3.6% | +37.5% | +22.1% | |
| – | – | – | – | – | – | +46.2% | +90.1% | -35.2% | +96.7% | -12.3% | +24.3% | -48.4% | +135.9% | +12.3% | -65.3% | +82.6% | -147.6% | – | +41.2% | +49.0% | -87.4% | +404.2% | +4.7% | +55.6% | +129.6% | -0.4% | -62.1% | -122.5% | – | |
| – | – | – | – | – | -10,158.3% | – | – | -33.8% | +65.6% | +5.6% | +40.7% | -114.8% | – | -25.9% | -96.9% | +2,043.6% | -172.2% | – | +499.7% | -70.6% | -436.8% | – | – | -507.7% | – | -26.9% | -60.0% | -184.7% | – | |
| – | – | – | – | – | – | +34.8% | -23.9% | -36.0% | +116.3% | -20.9% | +13.8% | +4.4% | +45.9% | +28.9% | -57.4% | +47.2% | -141.2% | – | -110.3% | – | -13.2% | -6.1% | -17.4% | +166.7% | +26.3% | +6.8% | -62.5% | -110.3% | – | |
| – | – | – | – | – | – | +25.6% | +88.7% | -25.3% | +90.6% | -15.3% | +14.5% | +17.9% | +71.5% | +2.6% | -23.9% | +9.5% | -65.6% | +329.9% | +13.6% | +18.5% | -41.6% | +78.2% | -7.3% | +19.9% | +36.7% | +5.0% | -33.4% | -24.5% | -268.8% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.